# A Dose-Escalating Study of Ro 31-8959 ( HIV Protease Inhibitor ) in Patients With HIV Disease.

> **NCT00002111** · PHASE1 · COMPLETED · sponsor: **Stanford University** · enrollment: 32 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Saquinavir

## Key facts

- **NCT ID:** NCT00002111
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 32 (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002111

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002111, "A Dose-Escalating Study of Ro 31-8959 ( HIV Protease Inhibitor ) in Patients With HIV Disease.". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00002111. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*